Percent ventricular pacing with managed ventricular pacing mode in standard pacemaker population

Europace

Volumn 10, Issue 2, 2008, Pages 151-155

  Milasinovic, Goran ^a   Tscheliessnigg, Karlheinz ^b   Boehmer, Anthonie ^c   Vancura, Vladimir ^d   Schuchert, Andreas ^e   Brandt, Johan ^f   Wiggenhorn, Christopher ^g   Hofman, Maaike ^h   Sperzel, Johannes ⁱ  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY HOSPITAL GRAZ   (Austria)

^c Zuyderland Medical Centre   (Netherlands)

^d INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g MEDTRONIC INC   (United States)

^h MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

ⁱ KERCKHOFF HEART CENTER   (Germany)

Author keywords

Atrioventricular block; Managed ventricular pacing; Pacing algorithms; Sinus node disease; Ventricular pacing

Indexed keywords

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; CALCULATION; FEMALE; FOLLOW UP; HEART VENTRICLE PACING; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PACEMAKER; POPULATION; PRIORITY JOURNAL; SINUS NODE DISEASE; ALGORITHM; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; EQUIPMENT; HEART BLOCK; HEART PACING; LABORATORY DIAGNOSIS; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; STATISTICS;

AGED; AGED, 80 AND OVER; ALGORITHMS; CARDIAC PACING, ARTIFICIAL; EQUIPMENT FAILURE; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HEART BLOCK; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 41949099386     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum288     Document Type: Article

References (15)

1. Tse HF, Lau CP. Long-term effect of right ventricular pacing on myocardial perfusion and function. J Am Coll Cardiol 1997;29:774- 9.
2. Tse HF, Yu C, Wong KK, Tsang V, Leung YL, Ho WY. Functional abnormalities in patients with permanent right ventricular pacing. J Am Coll Cardiol 2002;40:1451-8.
3. Nielsen JC, Kristensen L, Andersen HR, Mortensen PT, Pedersen O, Pedersen AK. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J Am Coll Cardiol 2003;42:614-23.
4. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;23:2932-7.
5. Wilkoff BL, Cook JR, Epstein AE, Green HL, Hallstrom AP, Hsia H et al. The DAVID Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-23.
6. Sharma AD, Rizo-Patron C, Hallstrom AP, O'Neill GP, Rothbart S, Martins JB et al. Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2005;2:830-4.
7. Sweeney MO, Ellenbogen KA, Casavant D, Betzold R, Sheldon T, Tang F et al. Multicenter, prospective, randomized safety and efficacy study of new atrial-based managed ventricular pacing mode (MVP) in dualchamber ICDs. J Cardiovasc Electrophysiol 2005;16:811-7.
8. Gillis AM, Pürerfellner H, Israel CW, Sunthorn H, Kacet S, Anelli-Monti M et al. Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block. PACE 2006;29:697-705.
9. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-61.
10. Sweeney MO, Shea JB, Fox V, Adler S, Nelson L, Mullen TJ et al. Randomized pilot study of a new atrial-based minimal ventricular pacing mode in dual-chamber implantable cardioverter-defibrillators. Heart Rhythm 2004;1:160-7.
11. Sweeney MO, Ruetz LL, Belk P, Mullen TJ, Johnson JW, Sheldon T. Bradycardia pacing induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia? J Am Coll Cardiol 2007;50:614-22.
12. Mansour F, Talajic M, Thibault B, Khairy P. Pacemaker troubleshooting: when MVP is not the most valuable parameter. Heart Rhythm 2006;3:612-4.
13. Pinski SL, Eguia L, Trohman RG. What is the minimal pacing rate that prevents Torsades de Pointes? Insights from patients with permanent pacemakers. Pacing Clin Electrophysiol 2002;25:1612-5.
14. Van Mechelen R. Schoonderwoerd. Risk of managed ventricular pacing in a patient with heart block. Heart Rhythm 2006;3:1384-5.
15. Sweeney MO, Bank AJ, Nsah E, Koullick M, Zeng QC, Hettrick D et al. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med 2007;357:1000-8.